𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetics of a novel antiangiogenic agent KR-31831 in rats

✍ Scribed by Sook J. Kim; Hong I. Lee; Hye Y. Ji; Ya Moon; In B. Paek; Sunkyung Lee; Kyu Y. Yi; Sun D. Yoo; Hye S. Lee

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
89 KB
Volume
26
Category
Article
ISSN
0142-2782

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dose-dependent pharmacokinetics of a new
Dose-dependent pharmacokinetics of a new neuroprotective agent for ischemia-reperfusion damage, KR-31378, in rats
✍ Hee J. Kim; So H. Kim; Sun-O. Kim; Dong-H. Lee; Hong Lim; Sung-E. Yoo; Myung G. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 1 views

## Abstract The dose‐dependent pharmacokinetic parameters of a new neuroprotective agent for ischemia‐reperfusion damage, KR‐31378, were evaluated after intravenous and oral administration, 10, 20, and 50 mg/kg, to rats. After intravenous administration of 50 mg/kg, the dose‐normalized (10 mg/kg) A

The pharmacokinetics of a novel anti-tum
The pharmacokinetics of a novel anti-tumor agent, β-elemene, in Sprague-Dawley rats
✍ Kun Wang; Zi Li; Yuren Chen; Chengye Su 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

beta-Elemene, a natural sesquiterpene, is a novel anti-tumor agent. The pharmacokinetics of beta-elemene after single i.v. administration have been investigated in male SD rats. beta-Elemene was administered at three doses (50, 75 and 100 mg/kg) and a full pharmacokinetic profile was obtained. beta-

Dose-dependent pharmacokinetics of a new
Dose-dependent pharmacokinetics of a new Na+/H+ exchanger inhibitor KR-33028 in rats
✍ Young Hoon Kim; Sun Dong Yoo; You Sun Kim; Kyung Hee Lee; Hye Suk Lee 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 2 views

## Abstract The dose‐dependency of the pharmacokinetics of a new Na^+^/H^+^ exchanger inhibitor, KR‐33028 was evaluated in rats after intravenous and oral administration. After intravenous administration of KR‐33028 (1, 5, 10 and 20mg/kg doses), the systemic clearance (__Cl__) was reduced and __AUC

Pharmacokinetic–pharmacodynamic analysis
Pharmacokinetic–pharmacodynamic analysis of the arrhythmogenic potency of a novel antiallergic agent, ebastine, in rats
✍ Hisakazu Ohtani; Hitoshi Sato; Tatsuji Iga; Hajime Kotaki; Yasufumi Sawada 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 2 views

Ebastine (EBS), a novel nonsedative antiallergic agent, is similar to terfenadine in its chemical structure. However, clinical arrhythmogenicity of EBS remains controversial. In this study, we evaluated the possible arrhythmogenic potency of EBS as assessed by QT prolongation from a pharmacokinetic-